News and Views


Nature Medicine 14, 485 - 487 (2008)
doi:10.1038/nm0508-485

bold beta-adrenergic signaling in heart failure—adapt or die

Thomas Eschenhagen1

  1. Thomas Eschenhagen is at the Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
    e-mail: t.eschenhagen@uke.uni-hamburg.de


About 25% of the African-American population carries a gene variant that seems to protect against heart failure. The findings may have implications for the use of beta-blockers (pages 510–517).

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.


Extra navigation

Subscribe to Nature Medicine

Subscribe

Search PubMed for

Open Innovation Challenges

  • Mitigating Zinc Corrosion

    • Deadline: Aug 23 2009
    • Reward: $20,000 USD

    The Seeker is looking for novel methods to mitigate zinc corrosion/gassing in alkaline media. This ...

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

natureproducts


ADVERTISEMENT